Capsule di prednisone ( DrugBank: Prednisone )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
41巨細胞性動脈炎1

41. 巨細胞性動脈炎


臨床試験数 : 128 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 124
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-001758-14-IT
(EUCTR)
08/06/201620/01/2021A study to assess the efficacy and safety of Sirukumab in the treatment ofpatients with Giant Cell Arteritis, using multiple sites, and an untreatedpatient groupA Multicenter, Randomized, Double-Blind, Placebo-Controlled,Parallel Group Study to Evaluate the Efficacy and Safety ofSirukumab in the Treatment of Patients with Giant Cell Arteritis - NA Giant Cell Arteritis (GCA)
MedDRA version: 20.0;Level: SOC;Classification code 10047065;Term: Vascular disorders;System Organ Class: 10047065 - Vascular disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Product Name: Sirukumab
Product Code: GSK2973327
INN or Proposed INN: Sirukumab
Other descriptive name: CNTO 136
Product Name: Sirukumab
Product Code: GSK2973327
INN or Proposed INN: Sirukumab
Trade Name: Capsule di prednisone
INN or Proposed INN: PREDNISONE
Trade Name: Prednisone Capsule
INN or Proposed INN: PREDNISONE
Other descriptive name: Over encapsulated prednisone
Trade Name: Prednisone capsule
INN or Proposed INN: PREDNISONE
Other descriptive name: Prednisone
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENTNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
204Phase 3United States;Spain;United Kingdom;Italy;France;Hungary;Belgium;Poland;Australia;Bulgaria;Germany;Netherlands;New Zealand;Sweden